Long‐term genetic and clinical remissions after cessation of azacitidine treatment in patients with VEXAS syndrome

• Anna M. Aalbers,
• Paul L. A. vanDaele,
• Virgil A. S. H. Dalm,
• Peter J. M. Valk,
• Marc H. G. P. Raaijmakers

Affiliations

Anna M. Aalbers

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands

Paul L. A. vanDaele

Department of Internal Medicine, Division of Allergy & Clinical Immunology, and Department of Immunology, Erasmus MC University Medical Center Rotterdam Rotterdam the Netherlands

Virgil A. S. H. Dalm

Department of Internal Medicine, Division of Allergy & Clinical Immunology, and Department of Immunology, Erasmus MC University Medical Center Rotterdam Rotterdam the Netherlands

Peter J. M. Valk

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands

Marc H. G. P. Raaijmakers

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam The Netherlands